This work is licensed under a Creative Commons Attribution 4.0 International License.
aStAx-41R
General Information
DRACP ID DRACP05952
Peptide Name aStAx-41R
Sequence RRWPRⓍILHⓍDVRRVAR
Sequence Length 17
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Stapled Peptides β-catenin inhibitor
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target β-catenin
Affinity Not available
Mechanism Inhibit wnt/β-catenin signaling pathway
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Cyclic (Stapled)
Disulfide/Other Bond Stapled: Ⓧ(6) and Ⓧ (10) are cross-linked by hydrocarbon stapling
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C87H144N36O16
Absent amino acids CEFGKMNQSTY
Common amino acids R
Mass 223589
Pl 12.8
Basic residues 7
Acidic residues 1
Hydrophobic residues 6
Net charge 6
Boman Index -8084
Hydrophobicity -104.12
Aliphatic Index 85.88
Half Life
/
Extinction Coefficient cystines 5500
Absorbance 280nm 343.75
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23071338
Title Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.